BioHarvest Sciences Inc.
BHST
$6.75
-$0.08-1.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.89M | -12.06M | -8.67M | -12.91M | -17.19M |
| Total Depreciation and Amortization | 1.53M | 1.50M | 1.45M | 1.25M | 1.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.79M | 3.58M | 737.00K | 5.53M | 9.25M |
| Change in Net Operating Assets | -793.00K | -49.00K | -48.00K | -555.00K | -475.00K |
| Cash from Operations | -7.36M | -7.03M | -6.53M | -6.68M | -7.29M |
| Capital Expenditure | -2.09M | -2.18M | -3.30M | -2.84M | -2.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00K | 37.00K | -188.00K | -192.00K | -185.00K |
| Cash from Investing | -2.10M | -2.14M | -3.49M | -3.03M | -2.92M |
| Total Debt Issued | 13.62M | 9.30M | 6.66M | 3.31M | 7.10M |
| Total Debt Repaid | -1.76M | -1.50M | -1.36M | -1.27M | -502.00K |
| Issuance of Common Stock | 5.84M | 0.00 | 4.73M | 4.74M | 4.74M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.70M | 7.80M | 10.02M | 6.78M | 11.34M |
| Foreign Exchange rate Adjustments | -40.00K | -64.00K | -35.00K | -34.00K | 81.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.20M | -1.44M | -35.00K | -2.97M | 1.21M |